Deleting the EGR system often sparks debate, but sometimes the simplest solution is also the most effective. Rather than overcomplicating the process, this approach focuses on reliability, cleanliness ...

LONDON, UNITED KINGDOM - January 14:2026 A photo illustration of A photo illustration of Ozempic.,on January 14 2026 in London, United Kingdom. (Photo by Peter Dazeley/Getty Images) Eli Lilly’s recent ...

Eli Lilly and Company (NYSE:LLY) is one of the best performing pharma stocks in 2025. Eli Lilly and Company (NYSE:LLY) announced on January 7 that it entered into a definitive agreement to acquire ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Blackrock Inc (Symbol: BLK), where a total volume of 3,272 contracts has been traded ...

I have written only two articles on LLY stock, the latest published in August 2025 with a "Buy" rating, which could have delivered 37-38% in total returns for buyers. While it looks a bit too ...

Financial giants have made a conspicuous bullish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co (NYSE:LLY) revealed 67 unusual trades. Delving into the details, we ...

Novo Nordisk was the first company to introduce a GLP-1 shot. Eli Lilly's GLP-1 shot quickly became the industry leader after its introduction. Novo Nordisk has now become the first drugmaker to ...

On the Jan. 5, 2026, episode of The Morning Filter podcast, Morningstar Chief US Market Strategist Dave Sekera commented on what the Food and Drug Administration’s approval of Novo Nordisk’s NVO ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with drugs addressing a promising target offering the potential ...